Yüklüyor......
Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma
The combination of clarithromycin, lenalidomide and dexamethasone (BiRd) has led to highly durable responses in newly diagnosed myeloma. However, the ability of clarithromycin to overcome resistance to lenalidomide and dexamethasone (Rd) is not known. To study this, we performed a retrospective anal...
Kaydedildi:
| Yayımlandı: | Am J Hematol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4390045/ https://ncbi.nlm.nih.gov/pubmed/24723438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23733 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|